Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 7, Number 6—December 2001

Legionella-Like and Other Amoebal Pathogens as Agents of Community-Acquired Pneumonia

Thomas J. Marrie*Comments to Author , Didier Raoult†, Bernard La Scola†, Richard J. Birtles†, Emidio de Carolis‡, and the Canadian Community-Acquired Pneumonia Study Group
Author affiliations: *Department of Medicine University of Alberta, Edmonton, Alberta, Canada;; †Faculté de Médecine de Marseille, Marseille, France;; ‡Pfizer Canada Inc., Montreal, Quebec, Canada

Main Article

Table 2

Summary of selected characteristics of four patients infected with Legionella-like amoebal pathogen (LLAP)-4

No. Age Sex Temp Symptoms LOS WBC Antibiotics Comments Antibody titer Co-pathogens
TM37 93 M 38.3 nausea, myalgia, shortness of breath, nonproductive cough, chest pain 8 18.2 erythromycin; cefuroxime admitted from a nursing home, sustained a non q wave myocardial infarction IgG 1:400 and 1:400 None
TM11 87 F 39.0 nonproductive cough, chills 11 8.7 erythromycin; cefuroxime IgG 0 and 1:100 None
ML13 54 M 38.4 abdominal pain, nonproductive cough, myalgia, chest pain 17 2.2 erythromycin; ceftazidime, ribavirin bone marrow transplant; required intensive care unit treatment IgM 25 and 0; IgG 200 and 1:400 RSV
LN 9
shortness of breath, chills
erythromycin, cefuroxime

IgM 1:200 and 1:200
Strepto-coccus pneumoniae

M = male; F = female; LOS = length of stay in days; wbc = leukocyte count; antibody titer = first value is from acute-phase sample and second from convalescent-phase sample.

Main Article

1R. Duperval, S. Field, T. Louie, S. Houston, M. Gribble, K. Williams, L. Nicolle, R. Grossman, I. Salit, R. Saginur, D. Gregson, M. Laverdiere, Jean Joly, T. Marrie, and J. Hutchinson.

Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.